Fournier’s Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications

Kinjal Kasbawala; George A. Stamatiades; Sachin K. Majumdar

doi:10.12659/AJCR.921536

02 June 2020 : Case report Netherlands Antilles

Fournier’s Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications

Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)

Kinjal Kasbawala^1BEF, George A. Stamatiades^23BEF*, Sachin K. Majumdar^2E

DOI: 10.12659/AJCR.921536

Am J Case Rep 2020; 21:e921536

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Fournier’s Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy